Publication:
Chemokine expression of oral fibroblasts and epithelial cells in response to artificial saliva.

cris.virtualsource.author-orcid81d9332e-ee47-4e6f-9f39-be4e71384e67
cris.virtualsource.author-orcid0637e067-2b53-4e82-b6a0-e613e3124539
cris.virtualsource.author-orcid6374ed29-695a-4f29-a8fb-dfd77c0b4972
cris.virtualsource.author-orcidb9759238-3279-417f-8a08-e944d9c17a04
datacite.rightsopen.access
dc.contributor.authorMüller, Heinz-Dieter
dc.contributor.authorCvikl, Barbara
dc.contributor.authorLussi, Adrian
dc.contributor.authorGruber, Reinhard
dc.date.accessioned2024-10-24T18:41:26Z
dc.date.available2024-10-24T18:41:26Z
dc.date.issued2016-06
dc.description.abstractOBJECTIVES Artificial saliva is widely used to overcome reduced natural salivary flow. Natural saliva provokes the expression of chemokines in oral fibroblasts in vitro. However, if artificial saliva changes the expression of chemokines remains unknown. MATERIALS AND METHODS Here, we investigated the ability of Saliva Orthana®, Aldiamed®, Glandosane®, and Saliva Natura® to change the expression of chemokines in human oral fibroblasts and the human oral epithelial cell line HSC-2 by means of reverse transcription polymerase chain reaction and immunoassays. Mucins isolated from bovine submaxillary glands and recombinant human mucin 1 were included in the bioassay. Formazan formation and LIVE/DEAD® staining determined the impact of artificial saliva on cell viability. The involvement of signaling pathways was determined by pharmacologic inhibitors and Western blotting. RESULTS In gingival fibroblasts, Saliva Orthana®-containing mucins provoked a significantly increased expression of CXC ligand 8 (CXCL8, or interleukin 8), CXCL1, and CXCL2. Immunoassays for CXCL8 and CXCL1 confirmed the translation at the protein level. The respective dilution of artificial saliva had no impact on formazan formation and LIVE/DEAD® staining. Mucins isolated from bovine submaxillary glands also increased the panel of chemokine expression in gingival fibroblasts. BAY 11-7082, a nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) inhibitor, but also TAK-242, an inhibitor of toll-like receptor 4 signaling, blocked chemokine expression of Saliva Orthana® and bovine mucins. In HSC-2 cells, Glandosane® significantly increased CXCL8 expression. CONCLUSIONS Saliva Orthana® stimulated chemokine expression in gingival fibroblasts. Mammalian mucins, but also possible contaminations with endotoxins, might contribute to the respective changes in gene expression. Epithelial cells have a differential response to artificial saliva with Glandosane® changing CXCL8 expression. CLINICAL RELEVANCE Artificial saliva can incite a cellular response, if however the changing expression of chemokines by isolated fibroblasts and epithelial cells in vitro translates into a clinical condition, is not clear.
dc.description.numberOfPages8
dc.description.sponsorshipZahnmedizinische Kliniken, Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin
dc.description.sponsorshipZahnmedizinische Kliniken (ZMK)
dc.description.sponsorshipZahnmedizinische Kliniken, Forschung Zahnerhaltung
dc.identifier.doi10.7892/boris.91467
dc.identifier.pmid26342602
dc.identifier.publisherDOI10.1007/s00784-015-1582-5
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/147181
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofClinical oral investigations
dc.relation.issn1432-6981
dc.relation.organizationDCD5A442C67DE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C680E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BE8FE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD25E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C67FE17DE0405C82790C4DE2
dc.subjectArtificial saliva
dc.subjectChemokines
dc.subjectGingival
dc.subjectInflammation
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleChemokine expression of oral fibroblasts and epithelial cells in response to artificial saliva.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
dspace.file.typetext
oaire.citation.endPage1042
oaire.citation.issue5
oaire.citation.startPage1035
oaire.citation.volume20
oairecerif.author.affiliationZahnmedizinische Kliniken (ZMK)
oairecerif.author.affiliationZahnmedizinische Kliniken, Forschung Zahnerhaltung
oairecerif.author.affiliationZahnmedizinische Kliniken (ZMK)
oairecerif.author.affiliationZahnmedizinische Kliniken, Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin
oairecerif.author.affiliation2Zahnmedizinische Kliniken (ZMK)
oairecerif.author.affiliation2Zahnmedizinische Kliniken, Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin
oairecerif.author.affiliation2Zahnmedizinische Kliniken, Forschung Zahnerhaltung
oairecerif.author.affiliation3Zahnmedizinische Kliniken, Klinik für Zahnerhaltung, Präventiv- und Kinderzahnmedizin
oairecerif.author.affiliation3Zahnmedizinische Kliniken, Forschung Oralchirurgie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.embargoChanged2021-07-01 00:30:01
unibe.description.ispublishedpub
unibe.eprints.legacyId91467
unibe.journal.abbrevTitleCLIN ORAL INVEST
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 2 of 2
Name:
Chemokine expression of oral fibroblasts and epithelial .pdf
Size:
716.79 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published
Name:
MS_Artif.saliva COI final to BORIS.pdf
Size:
673.5 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
accepted

Collections